First-in-Human Percutaneous Transcatheter Tricuspid Valve Replacement With a Novel Valve

Mordehay Vaturi; Hana Vaknin-Assa; Yaron Shapira; Leor Perl; Amos Levi; Arnon Koren; Ran Kornowski

doi:10.1016/j.jaccas.2021.06.014

First-in-Human Percutaneous Transcatheter Tricuspid Valve Replacement With a Novel Valve

JACC Case Rep. 2021 Aug 19;3(10):1281-1286. doi: 10.1016/j.jaccas.2021.06.014. eCollection 2021 Aug 18.

Authors

Mordehay Vaturi¹, Hana Vaknin-Assa¹, Yaron Shapira¹, Leor Perl¹, Amos Levi¹, Arnon Koren², Ran Kornowski¹

Affiliations

¹ Department of Cardiology, Rabin Medical Center, Petach Tikva, affiliated with the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
² Department of Vascular Surgery, Rabin Medical Center, Petach Tikva, affiliated with the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Abstract

The surgical intervention to treat isolated severe tricuspid regurgitation (TR) is challenging due to the severe TR patients' high-risk profile, hence associated with a high complication rate. Herein, we describe a first-in-human percutaneous deployment of a novel transcatheter prosthetic xenograft valve to treat severe TR. (Level of Difficulty: Advanced.).

Keywords: RCA, right coronary artery; RV, right ventricular; TEE, transesophageal echocardiography; TR, tricuspid regurgitation; right coronary artery; right ventricular; transesophageal echocardiography; tricuspid regurgitation.

Publication types

Case Reports